SEC Form 4 · accession 0001127602-15-022972
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Haluska
Officer — SVP, Clinical R&D, CMO
Period of report
Jul 15, 2015
Accepted (ET)
Jul 16, 2015 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | M | 8,000 | $0.00 | A | 122,124 | D | |
| Common Stock | Jul 16, 2015 | S | 4,400 | $8.5397 | D | 117,724 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance stock unitF3,F4 | — | Jul 15, 2015 | M | 8,000 | D | — | — | Common Stock | 8,000 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- F2Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- F3Each performance stock unit represents a right to receive one share of ARIAD common stock.
- F4The performance stock units vested on 7/15/15.